Novartis AGNVSNYSE
Loading
Selling, general, and administrative expenses
3Y CAGR
+3.0%/yr
vs -2.9%/yr prior
5Y CAGR
-1.3%/yr
Recent acceleration
Acceleration
+5.9pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.31B | +5.9% |
| 2024 | $12.57B | +0.4% |
| 2023 | $12.52B | +2.7% |
| 2022 | $12.19B | -4.9% |
| 2021 | $12.83B | -9.6% |
| 2020 | $14.20B | -1.2% |
| 2019 | $14.37B | +4.8% |
| 2018 | $13.72B | +10.0% |
| 2017 | $12.46B | -12.2% |
| 2016 | $14.19B | - |